ASSOCIATION BETWEEN SERUM IRISIN AND LEPTIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH LONG-STANDING TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY FROM CENTRAL INDIA

Main Article Content

Dr Sopan Sardesai
Dr Vaibhav Chaturvedi
Dr. Kanak Dwivedi
Dr Bhavika Mansharamani

Keywords

Type 2 diabetes mellitus, depression, irisin, leptin, PHQ-9, HAM-D, biomarkers, insulin resistance, cross-sectional study

Abstract

Type 2 diabetes mellitus (T2DM) is frequently associated with depression, which negatively affects glycaemic control and quality of life. Recent studies suggest that biomarkers such as irisin and leptin may play a role in the pathophysiology of depression.


Aim: To assess the association between serum irisin and leptin levels and depressive symptoms in patients with T2DM.


Materials and Methods: This was a cross-sectional study conducted over 6 months at the Department of Psychiatry, Index Medical College, Indore. A total of 86 patients with T2DM (≥5 years duration) were recruited. Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) and Hamilton Depression Rating Scale (HAM-D). Patients who screened positive on both scales were labelled as cases; others were classified as controls. Blood samples were analysed for serum irisin and leptin levels using ELISA. Statistical analysis included group comparisons and Spearman correlation.


Results: Out of 86 participants, 29 (33.7%) were classified as having depression. Serum irisin levels were significantly lower, while leptin levels were significantly higher in patients with depression compared to controls. Irisin showed a significant negative correlation with PHQ-9 and HAM-D scores (r = −0.62 and −0.59, respectively; p < 0.001), while leptin was positively correlated (r = 0.55 and 0.51, respectively; p < 0.001).


Conclusion: Low serum irisin and high serum leptin levels were strongly associated with depressive symptoms in patients with long-standing T2DM. These biomarkers may serve as useful indicators for early identification of depression in diabetic populations.

Abstract 74 | Pdf Downloads 10

References

1. Graham E, Desch E, Nes SS, Rosella LC, Schmitz N. Measures of depression and incident type 2 diabetes in a community sample. Ann Epidemiol. 2021;55.
2. Naicker K. Type 2 diabetes and comorbid symptoms of depression and anxiety: longitudinal associations with mortality risk. Diabetes Care. 2017;40.
3. Peng Y, Zhong S, Qin Y. The relationship between major depressive disorder and glucose parameters: a cross-sectional study in a Chinese population. Adv Clin Exp Med. 2017;26.
4. Trento M. A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol. 2012;49.
5. Strandberg RBOY, Graue M, Wentzel-Larsen T, Peyrot M, Rokne B. Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with hba1c in adult persons with type 1 diabetes. J Psychosom Res. 2014;77.
6. Webb M, Davies M, Ashra N, Bodicoat D, Brady E, Webb D, et al. The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women. PLoS One [Internet]. 2017;12(11):1–15.
7. Gorska-Ciebiada M, Ciebiada M. Association between Serum Irisin and Leptin Levels and Risk of Depressive Symptoms in the Diabetic Elderly Population. J Clin Med [Internet]. 2023;12(13).
8. Rana KS, Pararasa C, Afzal I, Nagel DA, Hill EJ, Bailey CJ, et al. Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels. Cardiovasc Diabetol [Internet]. 2017;16(1):147.
9. Li Z, Wang G, Zhu YJ, Li CG, Tang YZ, Jiang ZH, et al. The relationship between circulating irisin levels and tissues AGE accumulation in type 2 diabetes patients. Biosci Rep. 2017;37(3).
10. Gorska-Ciebiada M, Ciebiada M. Association between Serum Irisin and Leptin Levels and Risk of Depressive Symptoms in the Diabetic Elderly Population. J Clin Med. 2023;12(13).
11. Lee J, Yun JS, Ko SH. Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus. Nutrients [Internet]. 2022;14(15).
12. Ragab A, Sayed AR, GamalEl Din SF, Zeidan A, Ewis FF, Hamed MA. Evaluation of serum irisin level and severity of erectile dysfunction in diabetic males: a cross sectional prospective study. Diabetol Metab Syndr. 2024;16(1):233.
13. Xiang L, Xiang G, Yue L, Zhang J, Zhao L. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Atherosclerosis [Internet]. 2014;235(2):328–33.
14. Li Z, Wang G, Zhu YJ, Li CG, Tang YZ, Jiang ZH, et al. The relationship between circulating irisin levels and tissues AGE accumulation in type 2 diabetes patients. Biosci Rep. 2017;37(3).
15. Hou Q, Song R, Zhao X, Yang C, Feng Y. Lower circulating irisin levels in type 2 diabetes mellitus patients with chronic complications: A meta-analysis. Heliyon. 2023;9(11):e21859.
16. Cai J, Zhang S, Wu R, Huang J. Association between depression and diabetes mellitus and the impact of their comorbidity on mortality: evidence from a nationally representative study. J Affect Disord. 2024;354.
17. Stuart MJ, Baune BT. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev. 2012;36.
18. Abella V, Scotece M, Conde J, Pino J, Gonzalez-Gay MA, Gómez-Reino JJ, et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol [Internet]. 2017;13(2):100–9.
19. Sahin-Efe A, Upadhyay J, Ko BJ, Dincer F, Park KH, Migdal A, et al. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study. Metabolism [Internet]. 2018;79:24–32.
20. Hu W, Wang R, Li J, Zhang J, Wang W. Association of irisin concentrations with the presence of diabetic nephropathy and retinopathy. Ann Clin Biochem. 2016;53(1):67–74.
21. Lee HJ, Kim SH, Kim EY, Lee NY, Yu HY, Kim YS, et al. Leptin is associated with mood status and metabolic homeostasis in patients with bipolar disorder. Neuropsychobiology [Internet]. 2014;70(4):203–9.
22. Pan H, Guo J, Su Z. Advances in understanding the interrelations between leptin resistance and obesity. Physiol Behav [Internet]. 2014;130:157–69.